Physician profile
Sara Baig
NPI 1437248911
$12,183.06
in general payments reported to CMS, 2019-2025
48 companies · $2,426 in 2025
The $2,426 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,065 · 2020: $935 · 2021: $1,964 · 2022: $1,840 · 2023: $2,114 · 2024: $1,839 · 2025: $2,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,318 · Education: $61.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,318.37 |
| Education | $61.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,513.35 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $937.72 | 2019-2024 | Xarelto |
| Pfizer INC. | $823.42 | 2020-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $785.74 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $691.56 | 2019-2025 | Jardiance |
| Amgen INC. | $688.34 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $630.43 | 2020-2025 | Watchman Access System, Watchman, Mylux Patient Kit With Mobile Device |
| Astrazeneca Pharmaceuticals LP | $609.66 | 2019-2025 | Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $485.86 | 2021-2025 | Verquvo |
| Amarin Pharma, INC. | $471.01 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $383.17 | 2019-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $380.97 | 2021-2025 | Nexletol, Nexlizet |
| Scpharmaceuticals INC. | $339.57 | 2024-2025 | |
| Astellas Pharma US INC | $338.89 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $243.98 | 2019-2023 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $213.65 | 2022-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $196.16 | 2024 | Arcalyst |
| Heartflow, INC. | $194.22 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $187.35 | 2022-2025 | Assure Wcd |
| Chiesi USA, INC. | $186.08 | 2020-2021 | |
| Impulse Dynamics (USA) INC. | $185.22 | 2022-2025 | Optimizer, Optimizer |
| Sanofi-Aventis U.S. LLC | $183.02 | 2021-2024 | |
| Lundbeck LLC | $140.21 | 2019-2020 | |
| Daiichi Sankyo INC. | $137.53 | 2023 | Injectafer |
| Cvrx, INC. | $137.24 | 2023-2025 | Barostim Neo System |
| Abbott Laboratories | $130.55 | 2020-2025 | Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit, Navitor |
| Novo Nordisk INC | $128.09 | 2025 | Rybelsus, Ozempic, Wegovy |
| Actelion Pharmaceuticals US, INC. | $115.44 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $92.09 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $82.68 | 2020-2021 | |
| Medtronic, INC. | $53.70 | 2022 | |
| Alnylam Pharmaceuticals INC. | $52.58 | 2019-2023 | Onpattro |
| Gilead Sciences, INC. | $52.04 | 2019 | |
| Lantheus Medical Imaging, INC. | $46.46 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $37.04 | 2023 | Inpefa |
| Itamar Medical INC | $30.55 | 2025 | Watchpatone |
| Bardy Diagnostics, INC. | $30.45 | 2022 | |
| Amryt Pharma Holdings LTD | $29.97 | 2020-2021 | |
| Inari Medical, INC. | $29.64 | 2020-2021 | |
| Medtronic Vascular, INC. | $29.01 | 2019-2020 | |
| Asahi Intecc USA, INC. | $26.86 | 2025 | Asahi Coronary Wires |
| Arbor Pharmaceuticals, INC. | $26.07 | 2019-2020 | |
| Abiomed | $24.07 | 2024 | Impella |
| Zoll Circulation INC | $20.30 | 2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Lilly USA, LLC | $18.41 | 2025 | Kisunla |
| Baxter Healthcare | $17.11 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Vifor Pharma, INC. | $14.67 | 2019 | |
| Angiodynamics, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Baig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.